Cleared Traditional

REMEL SPECTRA MRSA (K092407) - FDA 510(k) Clearance

Class II Microbiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K092407 · Remel, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2010
Decision
428d
Days
Class 2
Risk

K092407 is an FDA 510(k) clearance for the REMEL SPECTRA MRSA. Classified as Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar (product code JSO), Class II - Special Controls.

Submitted by Remel, Inc. (Lenexa, US). The FDA issued a Cleared decision on October 8, 2010 after a review of 428 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1700 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Microbiology submissions.

View all Remel, Inc. devices

Submission Details

510(k) Number K092407 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 06, 2009
Decision Date October 08, 2010
Days to Decision 428 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
326d slower than avg
Panel avg: 102d · This submission: 428d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JSO Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JSO Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar

All 27
Devices cleared under the same product code (JSO) and FDA review panel - the closest regulatory comparables to K092407.
VRESELECT CULTURE MEDIUM
K103684 · Bio-Rad · Oct 2011
HARDYCHROM MRSA
K102922 · Hardy Diagnostics · May 2011
MRSA SELECT - SKIN AND SOFT TISSUE WOUND SPECIMENS
K100589 · Bio-Rad · Oct 2010
BBL CHROMAGAR MRSA II
K092767 · Becton, Dickinson & CO · Aug 2010
CHROMID VRE AGAR, MODEL: REF 43 851
K091025 · bioMerieux, Inc. · Mar 2010
CHROMID MRSA AGAR, MODEL: REF 43 841
K091024 · bioMerieux, Inc. · Jul 2009